Skip to main content
Top
Published in: Journal of Neuro-Oncology 2/2007

01-04-2007 | Clinical–Patient Studies

Gefitinib concentrations in human glioblastoma tissue

Authors: Silvia Hofer, Karl Frei

Published in: Journal of Neuro-Oncology | Issue 2/2007

Login to get access

Excerpt

Delivery of anticancer agents to solid tumors is not well investigated and studies analyzing drug concentrations in human tumor tissue, especially in the brain, are scarce. …
Literature
1.
go back to reference Hofer S, Frei K, Rutz HP (2006) Gefitinib accumulation in glioblastoma tissue. Cancer Biol Ther 5:483–484PubMedCrossRef Hofer S, Frei K, Rutz HP (2006) Gefitinib accumulation in glioblastoma tissue. Cancer Biol Ther 5:483–484PubMedCrossRef
2.
go back to reference Uhm JH, Haas-Kogan DA, Mischel PS (2006) Epidermal growth factor receptor in glioma: biology, prognosis and clinical trials. In: Educational book, Am Soc Clin Oncol, pp 85–91 Uhm JH, Haas-Kogan DA, Mischel PS (2006) Epidermal growth factor receptor in glioma: biology, prognosis and clinical trials. In: Educational book, Am Soc Clin Oncol, pp 85–91
3.
go back to reference Zhao M, Hartke C, Jimeno A et al (2005) Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 819:73–80PubMedCrossRef Zhao M, Hartke C, Jimeno A et al (2005) Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 819:73–80PubMedCrossRef
Metadata
Title
Gefitinib concentrations in human glioblastoma tissue
Authors
Silvia Hofer
Karl Frei
Publication date
01-04-2007
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2007
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-006-9257-3

Other articles of this Issue 2/2007

Journal of Neuro-Oncology 2/2007 Go to the issue